These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 30275230)

  • 1. Investigation of
    Kafadar D; Yaylim I; Kafadar AM; Cacina C; Ergen A; Kaynar MY; Isbir T
    Anticancer Res; 2018 Oct; 38(10):5991-5998. PubMed ID: 30275230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of survivin promoter polymorphisms with inflammatory bowel disease and response to antitumor necrosis factor therapy.
    Rapti E; Gazouli M; Legaki E; Karamanolis G; Thomas D; Marinos E; Papaconstantinou I
    Genet Test Mol Biomarkers; 2015 Jun; 19(6):339-43. PubMed ID: 25918954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between survivin gene polymorphisms and the susceptibility to colon cancer development in the Turkish population.
    Yamak N; Yaykasli KO; Yilmaz U; Eroz R; Uzunlar AK; Ankarali H; Sahiner C; Baltaci D
    Asian Pac J Cancer Prev; 2014; 15(20):8963-7. PubMed ID: 25374237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of survivin gene polymorphism with endometrial cancer.
    Zahedi P; Aminimoghaddam S; Sayahpour FA; Haghpanah V; Amiri P; Fereidoni F; Mahrampour E; Larijani B; Tavakkoly-Bazzaz J; Amoli MM
    Int J Gynecol Cancer; 2012 Jan; 22(1):35-7. PubMed ID: 21897272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of polymorphism in the survivin gene promoter as a potential risk factor for head and neck cancers development.
    Kostić M; Nikolić N; Ilić B; Carkić J; Milenković S; Vukadinović M
    Srp Arh Celok Lek; 2013; 141(5-6):304-7. PubMed ID: 23858797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms of survivin -31 G/C gene are associated with risk of urothelial carcinoma in Serbian population.
    Bogdanovic L; Lazic M; Bogdanovic J; Soldatovic I; Nikolic N; Radunovic M; Radojevic-Skodric S; Milasin J; Basta-Jovanovic G
    J BUON; 2017; 22(1):270-277. PubMed ID: 28365965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survivin Promoter Polymorphism (-31 C/G): A Genetic Risk Factor for Oral Cancer.
    Mehdi RF; Sheikh F; Khan R; Fawad B; Haq AU
    Asian Pac J Cancer Prev; 2019 Apr; 20(4):1289-1293. PubMed ID: 31031231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survivin gene promoter -31 G/C polymorphism is associated with Wilms tumor susceptibility in Serbian children.
    Radojevic-Skodric S; Basta-Jovanovic G; Brasanac D; Nikolic N; Bogdanovic L; Milicic B; Milasin J
    J Pediatr Hematol Oncol; 2012 Nov; 34(8):e310-4. PubMed ID: 22858571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survivin -31C/G polymorphism and gastric cancer risk in a Brazilian population.
    Borges Bdo N; Burbano RR; Harada ML
    Clin Exp Med; 2011 Sep; 11(3):189-93. PubMed ID: 21161671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional polymorphism -31C/G in the promoter of BIRC5 gene and risk of nasopharyngeal carcinoma among chinese.
    Ma F; Zhang H; Zhai Y; Huang W; Zhao C; Ou S; Zhou H; Yuan W; Wang Z; Wang H; Yue W; Yu L; Li P; Xia X; Cai M; Zhang Y; Cui Y; He F; Ma Y; Zhou G
    PLoS One; 2011 Feb; 6(2):e16748. PubMed ID: 21304814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survivin -31G/C promoter polymorphism and sporadic colorectal cancer.
    Gazouli M; Tzanakis N; Rallis G; Theodoropoulos G; Papaconstantinou I; Kostakis A; Anagnou NP; Nikiteas N
    Int J Colorectal Dis; 2009 Feb; 24(2):145-50. PubMed ID: 18946675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association between the survivin -31G/C promoter polymorphism and hepatocellular carcinoma risk in a Turkish population.
    Bayram S; Akkız H; Bekar A; Akgöllü E
    Cancer Epidemiol; 2011 Dec; 35(6):555-9. PubMed ID: 21296634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of survivin re-expression in the development and progression of non-small cell lung cancer.
    Javid J; Mir R; Julka PK; Ray PC; Saxena A
    Tumour Biol; 2015 Jul; 36(7):5543-50. PubMed ID: 25677909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A polymorphism in the promoter region of the survivin gene is related to hemorrhagic transformation in patients with acute ischemic stroke.
    Mallolas J; Rodríguez R; Gubern C; Camós S; Serena J; Castellanos M
    Neuromolecular Med; 2014 Dec; 16(4):856-61. PubMed ID: 25344020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of Serum Survivin and -31G/C Gene Polymorphism in the Early Diagnosis of Breast Cancer in Egypt.
    Motawi TMK; Zakhary NI; Darwish HA; Abdalla HM; Tadros SA
    Clin Breast Cancer; 2019 Apr; 19(2):e276-e282. PubMed ID: 30765238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphisms of survivin and its protein expression are associated with colorectal cancer susceptibility in Chinese population.
    Li XB; Li SN; Yang ZH; Cao L; Duan FL; Sun XW
    DNA Cell Biol; 2013 May; 32(5):236-42. PubMed ID: 23581553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of PD-1.5 C/T, but Not PD-1.3 G/A, with Malignant and Benign Brain Tumors in Iranian Patients.
    Namavar Jahromi F; Samadi M; Mojtahedi Z; Haghshenas MR; Taghipour M; Erfani N
    Immunol Invest; 2017 Jul; 46(5):469-480. PubMed ID: 28535114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of stromal cell-derived factor-1 and survivin gene polymorphisms on gastric cancer risk.
    Liarmakopoulos E; Theodoropoulos G; Vaiopoulou A; Rizos S; Aravantinos G; Kouraklis G; Nikiteas N; Gazouli M
    Mol Med Rep; 2013 Mar; 7(3):887-92. PubMed ID: 23258739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epistatic interaction between adiponectin and survivin gene polymorphisms in endometrial carcinoma.
    Aminimoghaddam S; Shahrabi-Farahani M; Mohajeri-Tehrani M; Amiri P; Fereidooni F; Larijani B; Shafiee G; Amoli MM
    Pathol Res Pract; 2015 Apr; 211(4):293-7. PubMed ID: 25613698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum Survivin Levels and Outcome of Chemotherapy in Patients with Malignant Mesothelioma.
    Goričar K; Kovač V; Franko A; Dodič-Fikfak M; Dolžan V
    Dis Markers; 2015; 2015():316739. PubMed ID: 26451067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.